Home/Filings/4/0001437749-22-014045
4//SEC Filing

Scott John K Jr. 4

Accession 0001437749-22-014045

CIK 0000810509other

Filed

May 31, 8:00 PM ET

Accepted

Jun 1, 4:35 PM ET

Size

6.2 KB

Accession

0001437749-22-014045

Insider Transaction Report

Form 4
Period: 2022-05-31
Transactions
  • Award

    Common Stock

    2022-05-31+2,5008,095,895 total
Holdings
  • Series G Redeemable Preferred Stock

    3,260
  • Common Stock

    (indirect: By Spouse)
    10,139
Footnotes (3)
  • [F1]Stock issued under the Amended and Restated 2014 Stock Incentive Plan in partial payment of monthly non-employee director fees.
  • [F2]Issuance deferred at the request of the Reporting Person.
  • [F3]Includes 2,639 shares of Common Stock owned by the Reporting Person's spouse and 7,500 shares of Common Stock owned by the Reporting Person's children. The Reporting Person may be deemed to have shared voting and/or dispositive power with respect to such shares.

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeother

Related Parties

1
  • filerCIK 0001753763

Filing Metadata

Form type
4
Filed
May 31, 8:00 PM ET
Accepted
Jun 1, 4:35 PM ET
Size
6.2 KB